ginsenoside rh2 has been researched along with Liver Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Chen, X; He, Z; Lin, Z; Liu, Z; Ma, J; Wang, Y; Xie, W; Yang, S | 1 |
| Hu, Y; Lang, Z; Tao, Q; Wang, H; Yu, S; Yu, Z; Zhang, J; Zheng, J; Zheng, L | 1 |
2 other study(ies) available for ginsenoside rh2 and Liver Cirrhosis
| Article | Year |
|---|---|
Ginsenoside Rh2 attenuates CDAHFD-induced liver fibrosis in mice by improving intestinal microbial composition and regulating LPS-mediated autophagy.
Topics: Animals; Autophagy; Ginsenosides; Hepatic Stellate Cells; Humans; Lipopolysaccharides; Liver; Liver Cirrhosis; Mice; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2022 |
Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11.
Topics: Amino Acid Transport System y+; Ferroptosis; Fibrosis; Hepatic Stellate Cells; Humans; Inflammation; Interferon Regulatory Factor-1; Iron; Liver Cirrhosis | 2023 |